Cephalon to acquire Mepha

Cephalon Inc. (NASDAQ:CEPH) will acquire generics company Mepha AG (Basel, Switzerland) for CHF622.5 million ($587.9 million) in cash. Cephalon said the deal will expand its range of products and double the size of its international business, expanding its reach in Europe, Africa and the Middle East. Mepha markets over 120 products in 50 countries and had 2009 sales of about CHF400 million ($377.8 million). Cephalon expects the acquisition to be accretive to its adjusted 2010 EPS. Deutsche Bank advised Cephalon on the deal, which is expected to close in the next 10-12 weeks. ...